Vie Ventures

Bridging venture capital and disease philanthropy
to develop breakthrough therapies

Vie Ventures operates at the intersection of venture capital and disease philanthropy.

Our team leverages decades of experience, a proven track record in life sciences venture capital, a returns-oriented approach, and a network of strategic collaborators from across the biotech and disease philanthropy ecosystems to advance life-changing therapies and cures for patients.

Latest News

Sep 17, 2025

Vie Ventures Convenes Inaugural Therapeutics Advisory Council to Advance Collaboration Among Autoimmune Disease Ecosystems

Sep 16, 2025

Blog Post:  Therapeutics Advisory Council Seeks to Drive Innovation in Autoimmune Disease Treatment

Jul 9, 2025

Veteran venture capitalists launch new firm to Vie for autoimmune success (FierceBiotech)

Jul 9, 2025

Vie Ventures Launches to Bankroll Autoimmune-Disease Biotechs (The Wall Street Journal)

Jul 9, 2025

Vie Ventures, New Life Sciences Venture Capital Firm, Launches to Advance Next Generation Therapies for Autoimmune Diseases